Show simple item record

dc.contributor.authorJames, Nicholas D.
dc.contributor.authorSpears, Melissa R.
dc.contributor.authorClarke, Noel W.
dc.contributor.authorDearnaley, David P.
dc.contributor.authorMason, Malcolm D.
dc.contributor.authorParker, Christopher C.
dc.contributor.authorRitchie, Alastair W. S.
dc.contributor.authorRussell, J. Martin
dc.contributor.authorSchiavone, Francesca
dc.contributor.authorAttard, Gerhardt
dc.contributor.authorde Bono, Johann S.
dc.contributor.authorBirtle, Alison
dc.contributor.authorEngeler, Daniel S.
dc.contributor.authorElliott, Tony
dc.contributor.authorMatheson, David
dc.contributor.authorO’Sullivan, Joe
dc.contributor.authorPudney, Delia
dc.contributor.authorSrihari, Narayanan
dc.contributor.authorWallace, Jan
dc.contributor.authorBarber, Jim
dc.contributor.authorSyndikus, Isabel
dc.contributor.authorParmar, Mahesh K. B.
dc.contributor.authorSydes, Matthew R.
dc.date.accessioned2018-01-30T09:31:16Z
dc.date.available2018-01-30T09:31:16Z
dc.date.issued2016-11-25
dc.identifier.citationFailure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer 2016, 2 (3):348 JAMA Oncology
dc.identifier.issn2374-2437
dc.identifier.doi10.1001/jamaoncol.2015.4350
dc.identifier.urihttp://hdl.handle.net/2436/621046
dc.description.sponsorshipThe Medical Research Council sponsored the study and was involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, and approval of the manuscript. Funding was also provided by Cancer Research UK, Astellas, Janssen, Novartis, Sanofi-Aventis, and Pfizer, none of which were directly involved in the research.
dc.language.isoen
dc.publisherAmerican Medical Association
dc.relation.urlhttp://oncology.jamanetwork.com/article.aspx?doi=10.1001/jamaoncol.2015.4350
dc.subjectfailure-free survival
dc.subjectradiotherapy
dc.subjectprostate cancer
dc.subjectnon-metastatic prostate cancer
dc.subjectSTAMPEDE
dc.titleFailure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer
dc.typeJournal article
dc.identifier.journalJAMA Oncology
dc.contributor.institutionWarwick Medical School, University of Warwick, Coventry, United Kingdom2University Hospitals Birmingham NHS Foundation Trust, The Medical School, University of Birmingham, Birmingham, United Kingdom
dc.contributor.institutionMedical Research Council Clinical Trials Unit, University College, London, United Kingdom
dc.contributor.institutionDepartment of Urology, Christie NHS Foundation Trust, Manchester, United Kingdom
dc.contributor.institutionInstitute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom
dc.contributor.institutionVelindre Hospital, Cardiff, United Kingdom
dc.contributor.institutionInstitute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom
dc.contributor.institutionMedical Research Council Clinical Trials Unit, University College, London, United Kingdom
dc.contributor.institutionInstitute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom
dc.contributor.institutionMedical Research Council Clinical Trials Unit, University College, London, United Kingdom
dc.contributor.institutionInstitute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom
dc.contributor.institutionInstitute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom
dc.contributor.institutionRoyal Preston Hospital, Preston, United Kingdom
dc.contributor.institutionCantonal Hospital St Gallen, St Gallen, Switzerland
dc.contributor.institutionGreater Manchester Group, Manchester, United Kingdom
dc.contributor.institutionLeeds Beckett University, Leeds, United Kingdom
dc.contributor.institutionBelfast City Hospital, Belfast, United Kingdom
dc.contributor.institutionSingleton Hospital, Swansea, United Kingdom
dc.contributor.institutionRoyal Shrewsbury Hospital, Shrewsbury, United Kingdom
dc.contributor.institutionBeatson West of Scotland Cancer Centre, Glasgow, United Kingdom
dc.contributor.institutionVelindre Hospital, Cardiff, United Kingdom
dc.contributor.institutionCCO Liverpool Warrington Aintree, Liverpool, United Kingdom
dc.contributor.institutionMedical Research Council Clinical Trials Unit, University College, London, United Kingdom
dc.contributor.institutionMedical Research Council Clinical Trials Unit, University College, London, United Kingdom
dc.source.volume2
dc.source.issue3
dc.source.beginpage348
dc.source.endpage357
refterms.dateFOA2018-08-20T13:40:58Z


Files in this item

Thumbnail
Name:
Matheson.pdf
Size:
447.5Kb
Format:
PDF
Description:
Main article

This item appears in the following Collection(s)

Show simple item record